Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-interacting protein 1 (RASIP1) is an adapter protein predominantly expressed in endothelial cells, where it functions as an effector for small GTPases such as Rap1 and Ras[2][5]. RASIP1 is essential for vascular development, mediating vasculogenesis and angiogenesis by regulating cytoskeletal organization, cell adhesion, and endothelial cell junction integrity[1][4][5]. Mechanistically, RASIP1 interacts with Rap1 and suppresses RhoA/ROCK signaling through recruitment of ARHGAP29, enabling proper cell spreading and maintaining vascular barrier function[1][3][4]. RASIP1 also binds directly to the cytoplasmic domain of the transmembrane protein Heart of Glass (HEG1), anchoring it to endothelial cell-cell junctions[4]. Knockdown or genetic deletion of RASIP1 leads to profound defects in blood vessel formation and vascular collapse[4][5], and genetic variants in RASIP1 have recently been associated with late-onset Alzheimer's disease risk[3]. No drugs are known to target RASIP1 directly, but its central role in vascular health makes it a potential therapeutic target for cardiovascular and inflammatory diseases, with notable risks if inhibited due to its essential role in endothelial function[4][5].
Adapter/linker for small GTPases (Rap1 and Ras), modulating RhoA and ROCK signaling. It interacts with ARHGAP29 to suppress RhoA signaling. RASIP1 maintains vascular integrity via cytoskeletal dynamics and cell junctions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-interacting protein 1 (RASIP1).